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INTRODUCTION
Hepatitis B virus (HBV) persistently infects approximately
350 million people worldwide, and induces a spectrum of
chronic liver disease ranging from chronic hepatitis through
liver cirrhosis to hepatocellular carcinoma (HCC) (1). The
persistent HBV carrier state is very frequently (up to 90%)
transmitted from infected mothers seropositive for hepatitis
B e antigen (HBeAg) to their babies (2, 3) and it used to be
responsible for the majority of persistent HBV infections in
Korea. 
Presence of hepatitis B core antigen (HBcAg) in the hep-
atocyte is related to the presence of HBeAg as a marker of
HBV replication, and usually connected with active inflam-
mation of liver disease (4, 5). However, HBV replication is
not always associated with hepatic damage. HBcAg has been
detected in the hepatocyte nucleus and cytoplasm in various
degrees (6, 7). The variability in these previous results may
be related to differences in the clinical features, race, age, and
region. An interesting issue raised is whether the degree of
expression of HBcAg in the hepatocyte nucleus and cytoplasm
reflects the level of viral replication and histological activity
in the same age population with chronic HBV infection. 
Two forms of chronic HBV infection are distinguished. One
of them is characterized by the high level of viremia, hepati-
tis B e antigen (HBeAg) and absence of anti-HBe antibodies.
Lack of HBeAg is usually connected with biochemically and
histologically inactive disease as well as with the significant
reduction of HBV replication, but up to 9% of such patients
show active inflammatory process despite anti-HBe serocon-
version (8, 9). 
The aim of study was to evaluate the degree of HBcAg in
the hepatocyte cytoplasm and nucleus and compare those re-
sults with histological activity of the disease as well as with
serum HBV DNA level according to HBeAg status in the
young patients with chronic B viral hepatitis.
MATERIALS AND METHODS
Patients and serological studies
One hundred-two patients (all men, mean age=19.7±1.4
yr old), who had been admitted to Wonkwang University
Medical Center in Iksan, Korea between 1999 and 2003 and
then diagnosed as seropositive for hepatitis B surface antigen
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The Degrees of Hepatocyte Cytoplasmic Expression of Hepatitis B
Core Antigen correlate with Histologic Activity of Liver Disease in the
Young Patients with Chronic Hepatitis B Infection
Subcellular localizaton of HBcAg have been found to be related to the activity of liver
disease and HBV replication. The aim of this study was to determine whether the
degree of expression of HBcAg in the hepatocyte nucleus and cytoplasm reflects
the level of viral replication and histological activity in chronic HBV infection. A total
of 102 patients with biopsy proven chronic hepatitis B were included. There was a
highly significant correlation between the levels of HBV DNA in serum and the degree
of expression of HBcAg in the nucleus for HBeAg-positive(p=0.000) and negative
patients(p=0.04). There was a highly significant, correlation between the degrees
of expression of HBcAg in hepatocyte cytoplasm and histologic activities (p<0.01)
for HBeAg-positive patients. The degrees of expression of HBcAg in the hepatocyte
cytoplasm correlated positively with the lobular activities (p<0.01), but not correlat-
ed with the portal activity and fibrosis for HBeAg-negative patients. In conclusion, in
the young patients with chronic B viral hepatitis, the degree of expression of HBcAg
in the hepatocyte nucleus may affect viral load, and the degree of expression of
HBcAg in the hepatocyte cytoplasm may affect histologic activities of liver disease.
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(HBsAg) for more than 6 months, were selected. Patients with
evidence of autoimmune hepatitis, Wilson’s disease, primary
biliary cirrhosis, anti-HCV positive, toxic and alcohol abusers
were excluded. They had never received any antiviral or im-
mune modulatory therapy. All patients gave informed con-
sents for the liver biopsy procedure. 
Laboratory assays 
HBsAg, antibody against hepatitis surface antigen (anti-
HBs), HBeAg, anti-HBe, anti-HCV, anti-HDV and anti-
HIV were determined by enzyme immunoassay (Abbott Lab-
oratories, Chicago, IL, U.S.A.). Serum HBV-DNA was assa-
yed by a hybridization assay (Digene Hybrid Capture Assay,
Digene Diagnostics, Gaithersburg, MD, U.S.A.). Lower and
upper detection limits of the assay were 5 and 2,000 pg/mL,
respectively. Levels of HBV DNA in sera were semiquanti-
tively scored on a scale of 0 to 5, which were values corre-
sponding to undetectable levels of <5, 6 to 50, 51 to 100, 101
to 150, 151 to 200, and >200 pg/mL, respectively. 
Histological examination and immunohistochemical stains
All liver biopsies were done within one week of blood sam-
pling. All were performed with Surecut needles (16G, TSK
Laboratory, Japan). Liver biopsy specimens were fixed in 10%
neutral-buffered formalin, embedded in paraffin. Sections
were cut at 4  m thick and stained with hematoxylin-eosin
and Masson’s trichrome. The liver histology was assessed by
a pathologist who was blind as to the results of the liver bio-
chemistry and HBV DNA levels. 
The histological diagnosis of chronic hepatitis was made
according to modified Histologic Activity Index (HAI) (11).
The activity and the stage of chronic hepatitis were evaluat-
ed and graded from 0 to 4. The hepatitis activities of lobu-
lar activity and portal/periportal activity were classified into
none, minimal, mild, moderate and severe grade. The stages
of fibrosis were classified into no fibrosis, portal fibrosis, peri-
portal fibrosis, and septal fibrosis, and cirrhosis.
Hepatocyte expression of HBcAg was studied by avidin-
biotin immunoperoxidase method (rabbit anti-HBcAg from
Zymed, San Francisco, CA, U.S.A.). The intracellular localiza-
tion of HBcAg was labelled as cytoplasmic, nuclear or cyto-
plasmic plus nuclear by evaluation of at least 1,000 cells. Neg-
ative control experiments were carried out by substituting
the primary antibody with phosphate-buffered saline. The
degree of expression of HBcAg in the hepatocyte cytoplasm
or nucleus was expressed as a proportion of the immunola-
belled cells, as previously reported. A scale of 0 to 3, which
were values corresponding to positivity in 0, 1 to 10, 11 to
50, and >50%, respectively, of hepatocytes examined, was
used in our study. 
Statistical analysis
Continuous variables with skewed distribution were com-
pared by a nonparametric test, Mann-Whitney U test. Cat-
egorial data were tested by an 
2 test or Fisher’s exact test.
Correlation between different continuous variables with ske-
wed distribution was tested by Spearman’s rank correlation.




The demographics, liver biochemistry, and HBV DNA
levels of all the patients are listed in Table 1. HBeAg-positive
patients had a higher median HBV DNA level compared to
HBeAg-negative patients (p=0.001). Among 27 patients
without HBeAg, inactive carrier (ALT within normal range)
was 15 (56%) and HBeAg negative hepatitis (increased ALT)
was 12 (44%). 
Sixty-nine of 75 (92.0%) patients with HBeAg and 16 of
27 (59%) patients without HBeAg had significant difference
for intrahepatic HBcAg staining (p=0.000). The HBcAg sta-
ining pattern of 69 patients with HBeAg was as follows (Table
2): 20 nuclear (30%), 47 both nuclear and cytoplasmic (68%)
and 2 cytoplasmic alone (2%). The HBcAg staining pattern
of 16 patients without HBeAg was as follows: 9 nuclear (56%),
4 both nuclear and cytoplasmic (25%) and 3 cytoplasmic
alone (19%). Patients with HBeAg had significantly higher
expression of mixed pattern of nuclei of intrahepatic HBcAg
than HBeAg-negative patients (p<0.001) (Table 2). 
Continous variables are expressed in median (range). Undetectable
HBV DNA level (<5 pg/mL) was accepted as 5 pg/mL. ALT, alanine ami-
notransferase; AST, aspartate aminotransferase. 
*p=0.001.
HBeAg-positive HBeAg-negative
No. of patients 75 27
Age (yr) 19.4 19.6
AST (U/L) 41 (7-832) 32 (15-225)
ALT (U/L) 72 (13-1532) 41 (14-562)
HBV DNA (pg/mL) 1,230 (5-7690)* 5 (5-474)
Table 1. Clinical and laboratory data of the patients studied
Data presented as number (percentage). Chi-square test, *p<0.0001.
Distribution pattern
of Intrahepatic HBcAg
Nuclear pattern 9 (56) 20 (30)
Cytoplasmic pattern 3 (19) 2 (3)
Mixed pattern 4 (25) 47 (67)*
Table 2. The distribution pattern of HBcAg in hepatocyte accord-
ing to HBeAg status
HBeAg
Negative (%) Positive (%)Relationship between the degree of expression of
HBcAg in hepatocyte nucleus and cytoplasm with the
histologic activity of liver disease
For HBeAg-positive patients, there was a highly significant
correlation between the degrees of expression of HBcAg in
the hepatocyte cytoplasm and lobular activities, and portal/
periportal activities (Spearman rank correlation coefficient
r=0.314, p=0.006 and r=0.283, p=0.01, respectively). There
was no significant correlation between fibrosis and the degree
of expression of HBcAg in the nucleus (r=0.023, p=0.84).
On the other hand, there was a negative correlation between
the degree of expression of HBcAg in the nucleus and lobu-
lar, and portal activities (r=-0.293, p=0.01 and r=-0.229, p=
0.04, respectively).
For HBeAg-negative patients, the degrees of expression of
HBcAg in the hepatocyte cytoplasm correlated positively
with the lobular activities (r=0.512, p=0.006, respectively),
but did not correlate with the portal activities and fibrosis.
On the other hand, no significant correlation between the de-
grees of expression of HBcAg in the hepatocyte nucleus and
histologic activities, and fibrosis was noted.
Relationship between the level of HBV DNA in serum
and the degrees of expression of HBcAg in the hepato-
cyte nucleus and cytoplasm 
For HBeAg-positive patients, there was a highly significant
correlation between the levels of HBV DNA in serum and
the degree of expression of HBcAg in the nucleus (r=0.507,
p=0.000). On the other hand, no significant correlation bet-
ween the level of HBV DNA in serum and the degree of
expression of HBcAg in the cytoplasm was noted (r=0.069,
p>0.5). 
For HBeAg-negative patients, there was a highly significant
correlation between the levels of HBV DNA in serum and
the degrees of expression of HBcAg in the nucleus and cyto-
plasm (r=0.392, p=0.043 and r=0.502, p=0.008, respectively).
Relationship between HBV DNA levels and with the 
histologic activity of liver disease
For HBeAg-positive patients, there were negative correla-
tions between HBV DNA levels and histological activities
(lobular activity and portal/periportal activity, p=0.05 and
0.02, respectively). For HBeAg-negative patients, HBV DNA
levels positively correlated with lobular activity (p=0.028)
while HBV DNA levels did not correlate with portal activi-
ty and fibrosis. 
DISCUSSION
In the previous results, the expression pattern of HBcAg
in hepatocytes was found to be related to the activity of liver
disease in chronic HBV infection (11) especially when HBcAg
was located in the cytoplasm of the hepatocyte (12). It also
was found that nuclear but not cytoplasmic expression of HB-
cAg is associated with high HBV replication and low activi-
ty of liver disease in the chronic B viral infection (13). In this
study, all these factors were assessed in the young age popu-
lation which enabled us to compare the effects of these factors
on the degree of HBcAg expression. The results suggested
that only the extent of nuclear HBcAg expression correlated
with HBV replication and also the extent of cytoplasmic HB-
cAg expression correlated with histological activity of liver
disease in chronic HBV infection. The limitation of this study
was that the HBV DNA levels were only measured at a sin-
gle time point and most of patients had mild or moderate
histologic activities of liver disease.
The interesting and significant finding was that there was
a positive correlation between the histologic activity of liver
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Statistical results was determined by Spearman rank correlation.
*p<0.05.
HBcAg HBcAg  HBV  Lobular  Portal Fibro-
nucleus cytoplasm DNA activity activity sis
HBcAg r 1.000 0.114 0.392 0.770 0.323 0.237
nucleus p 0.570 0.043* 0.059 0.100 0.236
HBcAg r 0.114 1.000 0.502 0.512 0.235 0.155
cytoplasm p 0.570 0.008* 0.006* 0.237 0.443
HBV DNA r 0.392 0.502 1.000 0.424 0.286 0.164
p 0.043* 0.008* 0.028* 0.148 0.412
Lobular r 0.770 0.512 0.424 1.000 0.571 0.472
activity p 0.059 0.006* 0.028* 0.002* 0.013
Portal r 0.323 0.235 0.286 0.571 1.000 0.472
activity p 0.100 0.237 0.148 0.002* 0.739
Fibrosis r 0.237 0.155 0.164 0.472 0.739 1.000
p 0.236 0.443 0.412 0.013 0.000*
Table 4. Relation of Histologic scores, HBV DNA and the deg-
rees of intrahepatic HBcAg expression in the HBeAg-negative
patients
Statistical results was determined by Spearman rank correlation. 
*p<0.05.
HBcAg HBcAg  HBV  Lobular  Portal Fibro-
nucleus cytoplasm DNA activity activity sis
HBcAg r 1.000 0.069 0.507 -0.293 -0.229 0.023
nucleus p 0.554 0.000* 0.011* 0.048* 0.846
HBcAg r 0.069 1.000 0.066 0.314 0.066 0.137
cytoplasm p 0.554 0.571 0.006* 0.571 0.242
HBV DNA r 0.507 0.066 1.000 -0.227 -0.280 -0.123
p 0.000* 0.571 0.050* 0.015* 0.293
Lobular r -0.293 0.314 -0.227 1.000 0.486 0.345
activity p 0.011* 0.006* 0.050* 0.000* 0.002*
Portal r -0.229 0.283 -0.280 0.486 1.000 0.458
activity p 0.048* 0.014* 0.015* 0.000* 0.000*
Fibrosis r 0.23 0.137 -0.123 0.345 0.458 1.000
p 0.846 0.242 0.293 0.002* 0.000*
Table 3. Clinical and laboratory data of the patients studied282 T.H. Kim, E.Y. Cho, H.J. Oh, et al.
disease and the degrees of expression of HBcAg in the hepa-
tocyte cytoplasm in both HBeAg-positive and -negative pa-
tients. In the HBeAg-positive patients, there was a inverse
correlation between the degree of expression of HBcAg in
the hepatocyte nucleus and the histological activity of liver
disease. This finding supported the importance of hepatocyte
injury in determination of HBcAg expression pattern. To our
knowledge, this could be the first study that the degree of
expression of HBcAg in the hepatocyte cytoplasm as assayed
by immunohistochemical techniques is helpful for estimat-
ing histological activity of liver disease in the young patients
with chronic HBV infection. This inverse relation could sug-
gest that the lysis of HBV infected hepatocytes was followed
not only with the decreasing of serum viral load but also the
degree of expression of HBcAg in the hepatocyte nucleus.
In 1987, Hsu et al. (7) showed that HBcAg was expressed
at a relatively higher level on the nucleus than on the cyto-
plasm during the immune tolerance phase, in which there
was little or no inflammatory activity in the liver, whereas
expression of HBcAg in the nuclei decreased with a concomi-
tant increase in the expression of HBcAg in cytoplasm dur-
ing the immune clearance phase, in which there is active and
ongoing hepatitis. Both studies postulated that expression
of HBcAg on the cell membrane is the important event that
triggers cytotoxic T cells with HBcAg receptors, resulting
in lysis of HBV-infected hepatocytes. Viral peptides, rather
than the whole viral antigen, are presented by the human
lymphocytes antigen (HLA) class I molecules to the cytotoxic
T cells in conjunction with adhesion molecules (14). The exact
mechanism by which viral peptides are being incorporated
into the HLA molecules was fully understood. The positive
relationship between the degree of expression of HBcAg in
the hepatocyte cytoplasm and histologic activity of liver dis-
ease supported that high level expression of HBcAg in the
cytoplasm could reflect an increase in the availability of HB-
cAg for intracellular processing into the HLA molecules, and
presentation as immune target to the cytotoxic T cells. In
1995, Chu et al. (12) denied the above-mentioned postulation
and concluded that the cytoplasmic localization of HBcAg
in patients with active hepatitis may be secondary to liver
damage and regeneration. 
In the present study, the interesting other finding was that
there was a highly significant positive correlation between
the levels of HBV DNA in serum and the degrees of expres-
sion of HBcAg in the hepatocyte nucleus, but there was no
correlation between the degree of expression of HBcAg in the
hepatocyte cytoplasm and the level of viral replication in the
HBeAg-positive patients. Our result confirmed the relation-
ship between nuclear HBcAg expression and viral replication.
It has been shown that HBcAg was localized in the nucleus
in quiescent cells but diminished in proliferating cells, and
the replication of HBV was enhanced in quiescent cells but
diminished in the proliferating cells (12). Expression of HB-
cAg in the hepatocyte nucleus was likely to be important in
viral replication. 
However, the mechanism for a significant correlation bet-
ween the level of HBV DNA in serum and the degrees of
expression of HBcAg in the hepatocyte nucleus rather than
in the cytoplasm has remained unclear. HBcAg was a trans-
lational product of the pre-core/core gene of HBV and the
carboxyl-terminal arginine-rich region of HBcAg has a nucle-
ar localization signal (15). After entry into hepatocytes and
transportation of the uncoated virus into the nucleus, viral
DNA exists as a covalently closed circular (ccc) DNA, which
serves as the template for transcription of pregenomic RNA
(16). Some pregenomic RNAs was transported to the cytosol
where formation of the viral nucleocapsid occurs along with
the polymerase into core particles (17). Cytoplasmic core-pac-
ked viral DNA could also reenter the nucleus to amplify nu-
clear ccc DNA which in turn could provide more viral DNA
for the production of new virions (18, 19). Our finding of a
significant correlation between the degrees of HBcAg expres-
sion in the hepatocyte nucleus and the level of viral replica-
tion in chronic HBV infection supports this re-entry ampli-
fying mechanism. 
Though HBeAg seroconversion was commonly taken as a
therapeutic endpoint in the past, increasing evidence showed
that disease progression can continue in a significant portion
of patients after HBeAg seroconversion, especially in the Asia
and Mediterranean population (20, 21). We found that there
was correlation between HBV DNA levels with lobular activi-
ty of liver disease in the HBeAg-negative which is in agree-
ment with other previous studies (22, 23). This finding con-
firms that active viral replication is still present in a certain
proportion of HBeAg-negative patients, and increased HBV
DNA might be used as a marker to identify HBeAg-nega-
tive patients who have a higher risk of active liver disease.
Some HBeAg-negative patients who have the inflammatory
response and viral clearance might have precore mutation or/
and core promoter mutations to escape immune clearance
(24-27). In contrast, one reported that core promotor muta-
tions were not associated with the enhanced viral replication
(28). These mutations and unknown other factors may be
related to the localization of HBcAg in the hepatocyte, there-
fore the virus might gradually replicate and develop inflam-
matory response in the liver. More studies are required to doc-
ument whether core promotor mutations have any effects on
the chronic hepatitis B disease.
Our study had limitations similar to those of other cross-
sectional studies (8, 13, 28). As hepatic inflammation may
fluctuate with time, we can not be absolutely sure of the final
outcome of these patients. This issue could only be satisfactori-
ly addressed by a longitudinal study with paired liver biopsies.
In conclusion, the degrees of cytoplasmic HBcAg expres-
sion correlated with histological activity of liver and also the
degrees of nuclear HBcAg expression correlated with HBV
replication in the young patients with chronic HBV infection.
These finding leads to the proposition that the nuclear local-HBcAg Expression and Activity in Chronic B Viral Hepatitis 283
ization of HBcAg may amplify ccc DNA in the replication
period of HBV and cytoplasmic localization may induce inter-
action between T cell and infected hepatocyte.
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